ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
Drug persistence and compliance affect patient-reported outcomes in overactive bladder syndrome
Quality of Life Research
◽
10.1007/s11136-015-1216-z
◽
2015
◽
Vol 25
(8)
◽
pp. 2021-2029
◽
Cited By ~ 7
Author(s):
Tae Heon Kim
◽
Myung-Soo Choo
◽
Young-Joo Kim
◽
Hyein Koh
◽
Kyu-Sung Lee
Keyword(s):
Overactive Bladder
◽
Patient Reported Outcomes
◽
Overactive Bladder Syndrome
◽
Patient Reported
Download Full-text
Related Documents
Cited By
References
1006 TREATING PATIENTS' MOST BOTHERSOME SYMPTOM OF OVERACTIVE BLADDER SYNDROME: PATIENT-REPORTED OUTCOMES FROM A LARGE OPEN-LABEL TRIAL OF SOLIFENACIN
European Urology Supplements
◽
10.1016/s1569-9056(07)61001-x
◽
2007
◽
Vol 6
(2)
◽
pp. 274
Author(s):
W. Steers
◽
M. Andoh
◽
S. Forero-Schwanhaeuser
Keyword(s):
Overactive Bladder
◽
Patient Reported Outcomes
◽
Overactive Bladder Syndrome
◽
Syndrome Patient
◽
Open Label
◽
Patient Reported
◽
Bothersome Symptom
◽
Open Label Trial
Download Full-text
1959 MIRABEGRON IMPROVES PATIENT-REPORTED OUTCOMES IN PATIENTS WITH OVERACTIVE BLADDER SYNDROME - RESULTS FROM A NORTH-AMERICAN STUDY
The Journal of Urology
◽
10.1016/j.juro.2011.02.2163
◽
2011
◽
Vol 185
(4S)
◽
Cited By ~ 5
Author(s):
Victor Nitti
◽
Sender Herschorn
◽
Stephen Auerbach
◽
Nancy Martin
◽
Mary Beth Blauwet
◽
...
Keyword(s):
Overactive Bladder
◽
North American
◽
Patient Reported Outcomes
◽
Overactive Bladder Syndrome
◽
American Study
◽
North American Study
◽
Patient Reported
Download Full-text
268 Drug persistence and compliance affecting patient reported outcomes in overactive bladder syndrome patient
European Urology Supplements
◽
10.1016/s1569-9056(15)60265-2
◽
2015
◽
Vol 14
(2)
◽
pp. e268
Author(s):
T.H. Kim
◽
M.S. Choo
◽
K-S. Lee
Keyword(s):
Overactive Bladder
◽
Patient Reported Outcomes
◽
Overactive Bladder Syndrome
◽
Syndrome Patient
◽
Patient Reported
Download Full-text
Antimuscarinic Agent Treatment Affecting Patient-Reported Outcomes in Overactive Bladder Syndrome With Depressive Symptoms
International Neurourology Journal
◽
10.5213/inj.1624678.339
◽
2016
◽
Vol 20
(4)
◽
pp. 349-355
Author(s):
Kyu Shik Kim
◽
Hong Sang Moon
Keyword(s):
Depressive Symptoms
◽
Overactive Bladder
◽
Patient Reported Outcomes
◽
Overactive Bladder Syndrome
◽
Antimuscarinic Agent
◽
Patient Reported
◽
Agent Treatment
Download Full-text
Factors Associated with Improvements in Patient-Reported Outcomes During Mirabegron or Antimuscarinic Treatment of Overactive Bladder Syndrome: A Registry Study (PERSPECTIVE)
Advances in Therapy
◽
10.1007/s12325-019-00994-7
◽
2019
◽
Vol 36
(8)
◽
pp. 1906-1921
◽
Cited By ~ 1
Author(s):
Kevin V. Carlson
◽
Eric S. Rovner
◽
Kavita V. Nair
◽
Anna S. Deal
◽
Rita M. Kristy
◽
...
Keyword(s):
Overactive Bladder
◽
Patient Reported Outcomes
◽
Overactive Bladder Syndrome
◽
Registry Study
◽
Factors Associated
◽
Patient Reported
◽
Study Perspective
Download Full-text
Faculty Opinions recommendation of Combination treatment with mirabegron and solifenacin in patients with overactive bladder: exploratory responder analyses of efficacy and evaluation of patient-reported outcomes from a randomized, double-blind, factorial, dose-ranging, Phase II study (SYMPHONY).
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
◽
10.3410/f.726641973.793540485
◽
2017
◽
Author(s):
Lori Ann Birder
Keyword(s):
Overactive Bladder
◽
Phase Ii
◽
Combination Treatment
◽
Patient Reported Outcomes
◽
Phase Ii Study
◽
Double Blind
◽
Patient Reported
◽
Dose Ranging
Download Full-text
A prospective study of elderly initiating mirabegron versus antimuscarinics: Patient reported outcomes from the Overactive Bladder Satisfaction Scales and other instruments
Neurourology and Urodynamics
◽
10.1002/nau.23271
◽
2017
◽
Vol 37
(1)
◽
pp. 177-185
◽
Cited By ~ 5
Author(s):
Suvapun Bunniran
◽
Cralen Davis
◽
Rita Kristy
◽
Daniel Ng
◽
Carol R. Schermer
◽
...
Keyword(s):
Overactive Bladder
◽
Prospective Study
◽
Patient Reported Outcomes
◽
Patient Reported
◽
A Prospective Study
Download Full-text
Solifenacin for Overactive Bladder: Patient-Reported Outcomes from a Large Placebo-Controlled Trial
Postgraduate Medicine
◽
10.3810/pgm.2009.09.2062
◽
2009
◽
Vol 121
(5)
◽
pp. 151-158
◽
Cited By ~ 14
Author(s):
Marc R. Toglia
◽
Scott R. Serels
◽
Christine Laramee
◽
Mickey M. Karram
◽
Indrani M. Nandy
◽
...
Keyword(s):
Overactive Bladder
◽
Patient Reported Outcomes
◽
Controlled Trial
◽
Patient Reported
Download Full-text
190 SOLIFENACIN SIGNIFICANTLY IMPROVES OVERACTIVE BLADDER (OAB) SYMPTOMS, SYMPTOM-ASSOCIATED BOTHER AND OTHER PATIENT-REPORTED OUTCOMES: RESULTS FROM VIBRANT, A DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL
European Urology Supplements
◽
10.1016/s1569-9056(09)60195-0
◽
2009
◽
Vol 8
(4)
◽
pp. 168
◽
Cited By ~ 1
Author(s):
T.A. Samuels
◽
H.D. Mitcheson
◽
M.D. Vardy
◽
S. Forero-Schwanhaeuser
◽
T. Marshall
◽
...
Keyword(s):
Overactive Bladder
◽
Patient Reported Outcomes
◽
Controlled Trial
◽
Double Blind
◽
Double Blind Placebo
◽
Patient Reported
Download Full-text
Patient Reported Outcomes(Pros) in Patients with Lower Urinary Track Symptom(Luts)/Benign Prostatic Hyperplasia(Bph) Accompanied with Overactive Bladder(Oab) in Korea
Value in Health
◽
10.1016/j.jval.2014.08.561
◽
2014
◽
Vol 17
(7)
◽
pp. A812
Author(s):
J.Y. Lee
◽
Y.H. Park
◽
Y.J. Kim
Keyword(s):
Benign Prostatic Hyperplasia
◽
Overactive Bladder
◽
Patient Reported Outcomes
◽
Prostatic Hyperplasia
◽
Patient Reported
◽
Lower Urinary
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close